Abiopharma

XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

(10% Negative) Fortress Biotech Inc. (FBIOP) Announces Delay in issued Development Timeline Due to Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Illumina, Inc. - Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery

Inotiv - Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery

Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery

Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain

(98% Neutral) PerkinElmer Inc. (the company was transformed to Revvity Inc (NYSE : RVTY)) (PKI) Reports Q1 2026 Financial Results

(99% Neutral) Illumina Inc (ILMN) Reports Q1 2026 Financial Results

(76% Positive) Vericel Corporation (VCEL) Reports Q1 2026 Financial Results

Illumina, Inc. - Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025

Baxter - Baxter Introduces the Dynamo Series, a New Smart Stretcher to Help Address Common Challenges in Hospital Settings

Hologic - Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer Screening

(99% Neutral) Coherus BioSciences Inc (CHRS) Files Form 8-K

(99% Positive) Aclarion Inc (ACONW) Announces Enrollment Update for partnerships Due to Patient Enrollment Issues, Regulatory Process

Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025